New Zealand markets closed

Koninklijke Philips NV (PHI1.BE)

Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
24.150.00 (0.00%)
As of 08:09AM CEST. Market open.
Full screen
Previous close24.15
Open24.15
Bid24.07 x 20000
Ask24.15 x 34300
Day's range24.15 - 24.15
52-week range16.06 - 27.37
Volume34
Avg. volume65
Market capN/A
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings date29 Jul 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Yahoo Finance Video

    Eli Lilly seeks to expand Zepbound use to treat sleep apnea

    Eli Lilly (LLY) is reporting success in the use of Zepbound — one of the pharmaceutical giant's landmark GLP-1 weight-loss drugs — to treat sleep apnea. Yahoo Finance Health Reporter Anjalee Khemlani joins The Morning Brief to discuss Eli Lilly's filing for approval from the US Food and Drug Administration (FDA) for this use case and how it may affect makers of CPAP (Continuous Positive Airway Pressure) sleep devices, such as Philips (PHG) and ResMed (RMD). For more expert insight and the latest market action, click here to watch this full episode of Morning Brief. This post was written by Luke Carberry Mogan.

  • GlobeNewswire

    Philips completes cancellation of 4.4 million shares

    June 19, 2024 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG; AEX: PHIA) today announced that it has completed the cancellation of 4,437,164 of its shares. The cancelled shares were acquired as part of the completed EUR 1.5 billion share repurchase program for capital reduction purposes that was announced on July 26, 2021. Philips’ current issued share capital amounts to EUR 187,987,876.80 representing 939,939,384 common shares. More information is available here. For further information,

  • Business Wire

    88% of US Healthcare Leaders say the use of automation for repetitive tasks is critical for addressing staff shortages in new Philips Future Health Index

    CAMBRIDGE, Mass., June 18, 2024--The Future Health Index (FHI) survey conducted by Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, explores the ongoing staffing and access challenges within the US healthcare system and the innovative solutions being used to address them. The ninth annual report, Better care for more people, demonstrates the pressures of staffing shortages and burnout on clinicians and their ability to deliver timely, high-quality care to patients. It